403 related articles for article (PubMed ID: 16537455)
41. Enhancing PPARγ by HDAC inhibition reduces foam cell formation and atherosclerosis in ApoE deficient mice.
Gao Q; Wei A; Chen F; Chen X; Ding W; Ding Z; Wu Z; Du R; Cao W
Pharmacol Res; 2020 Oct; 160():105059. PubMed ID: 32621955
[TBL] [Abstract][Full Text] [Related]
42. Dihydromyricetin ameliorates foam cell formation via LXRα-ABCA1/ABCG1-dependent cholesterol efflux in macrophages.
Zeng Y; Peng Y; Tang K; Wang YQ; Zhao ZY; Wei XY; Xu XL
Biomed Pharmacother; 2018 May; 101():543-552. PubMed ID: 29505925
[TBL] [Abstract][Full Text] [Related]
43. TRIM13 reduces cholesterol efflux and increases oxidized LDL uptake leading to foam cell formation and atherosclerosis.
Govatati S; Kumar R; Boro M; Traylor JG; Orr AW; Lusis AJ; Rao GN
J Biol Chem; 2024 May; 300(5):107224. PubMed ID: 38537695
[TBL] [Abstract][Full Text] [Related]
44. UFM1 Protects Macrophages from oxLDL-Induced Foam Cell Formation Through a Liver X Receptor α Dependent Pathway.
Pang Q; Xiong J; Hu XL; He JP; Liu HF; Zhang GY; Li YY; Chen FL
J Atheroscler Thromb; 2015; 22(11):1124-40. PubMed ID: 26040753
[TBL] [Abstract][Full Text] [Related]
45. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
46. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
[TBL] [Abstract][Full Text] [Related]
47. EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1.
Tsai JY; Su KH; Shyue SK; Kou YR; Yu YB; Hsiao SH; Chiang AN; Wu YL; Ching LC; Lee TS
Cardiovasc Res; 2010 Dec; 88(3):415-23. PubMed ID: 20615914
[TBL] [Abstract][Full Text] [Related]
48. Chlorogenic acid protects against atherosclerosis in ApoE-/- mice and promotes cholesterol efflux from RAW264.7 macrophages.
Wu C; Luan H; Zhang X; Wang S; Zhang X; Sun X; Guo P
PLoS One; 2014; 9(9):e95452. PubMed ID: 25187964
[TBL] [Abstract][Full Text] [Related]
49. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
[TBL] [Abstract][Full Text] [Related]
50. Quercetin increases macrophage cholesterol efflux to inhibit foam cell formation through activating PPARγ-ABCA1 pathway.
Sun L; Li E; Wang F; Wang T; Qin Z; Niu S; Qiu C
Int J Clin Exp Pathol; 2015; 8(9):10854-60. PubMed ID: 26617799
[TBL] [Abstract][Full Text] [Related]
51. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.
Li AC; Binder CJ; Gutierrez A; Brown KK; Plotkin CR; Pattison JW; Valledor AF; Davis RA; Willson TM; Witztum JL; Palinski W; Glass CK
J Clin Invest; 2004 Dec; 114(11):1564-76. PubMed ID: 15578089
[TBL] [Abstract][Full Text] [Related]
52. Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport.
Peng Y; Xu J; Zeng Y; Chen L; Xu XL
Phytomedicine; 2019 Sep; 62():152935. PubMed ID: 31085374
[TBL] [Abstract][Full Text] [Related]
53. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
54. TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis.
Guo X; Li B; Wen C; Zhang F; Xiang X; Nie L; Chen J; Mao L
Cell Mol Life Sci; 2023 May; 80(5):137. PubMed ID: 37133566
[TBL] [Abstract][Full Text] [Related]
55. Laser capture microdissection for analysis of macrophage gene expression from atherosclerotic lesions.
Feig JE; Fisher EA
Methods Mol Biol; 2013; 1027():123-35. PubMed ID: 23912984
[TBL] [Abstract][Full Text] [Related]
56. Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice.
Wan W; Lionakis MS; Liu Q; Roffê E; Murphy PM
Cardiovasc Res; 2013 Mar; 97(3):580-8. PubMed ID: 23180724
[TBL] [Abstract][Full Text] [Related]
57. Hawthorn (Crataegus pinnatifida Bunge) leave flavonoids attenuate atherosclerosis development in apoE knock-out mice.
Dong P; Pan L; Zhang X; Zhang W; Wang X; Jiang M; Chen Y; Duan Y; Wu H; Xu Y; Zhang P; Zhu Y
J Ethnopharmacol; 2017 Feb; 198():479-488. PubMed ID: 28119096
[TBL] [Abstract][Full Text] [Related]
58. Activation of soluble guanylyl cyclase prevents foam cell formation and atherosclerosis.
Tsou CY; Chen CY; Zhao JF; Su KH; Lee HT; Lin SJ; Shyue SK; Hsiao SH; Lee TS
Acta Physiol (Oxf); 2014 Apr; 210(4):799-810. PubMed ID: 24299003
[TBL] [Abstract][Full Text] [Related]
59. PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway.
Tang SL; Chen WJ; Yin K; Zhao GJ; Mo ZC; Lv YC; Ouyang XP; Yu XH; Kuang HJ; Jiang ZS; Fu YC; Tang CK
Atherosclerosis; 2012 Jun; 222(2):344-54. PubMed ID: 22503545
[TBL] [Abstract][Full Text] [Related]
60. Thrombin-Par1 signaling axis disrupts COP9 signalosome subunit 3-mediated ABCA1 stabilization in inducing foam cell formation and atherogenesis.
Boro M; Govatati S; Kumar R; Singh NK; Pichavaram P; Traylor JG; Orr AW; Rao GN
Cell Death Differ; 2021 Feb; 28(2):780-798. PubMed ID: 32968199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
